Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urology | 5 | 2025 | 87 | 2.160 |
Why?
|
| Nephrectomy | 7 | 2025 | 180 | 2.040 |
Why?
|
| Urolithiasis | 3 | 2025 | 9 | 1.810 |
Why?
|
| Kidney Calculi | 3 | 2024 | 49 | 1.780 |
Why?
|
| Ureteroscopy | 2 | 2025 | 20 | 1.660 |
Why?
|
| Lithotripsy, Laser | 2 | 2025 | 19 | 1.440 |
Why?
|
| Internship and Residency | 7 | 2025 | 1248 | 1.260 |
Why?
|
| Robotic Surgical Procedures | 3 | 2025 | 218 | 1.180 |
Why?
|
| Kidney Neoplasms | 4 | 2019 | 453 | 1.040 |
Why?
|
| Microbubbles | 1 | 2025 | 10 | 0.940 |
Why?
|
| Nephrolithotomy, Percutaneous | 1 | 2024 | 5 | 0.920 |
Why?
|
| Workload | 1 | 2025 | 150 | 0.850 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2025 | 193 | 0.830 |
Why?
|
| Nutritional Status | 1 | 2025 | 327 | 0.790 |
Why?
|
| Ureter | 1 | 2024 | 99 | 0.770 |
Why?
|
| Frailty | 1 | 2025 | 135 | 0.770 |
Why?
|
| Malnutrition | 1 | 2025 | 220 | 0.740 |
Why?
|
| Laparoscopy | 6 | 2019 | 522 | 0.710 |
Why?
|
| Urinary Tract | 1 | 2022 | 67 | 0.700 |
Why?
|
| Myelolipoma | 1 | 2020 | 3 | 0.670 |
Why?
|
| Kidney Transplantation | 2 | 2024 | 569 | 0.660 |
Why?
|
| Adrenalectomy | 1 | 2020 | 40 | 0.660 |
Why?
|
| Back Pain | 1 | 2019 | 31 | 0.630 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2019 | 38 | 0.620 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 78 | 0.620 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2012 | 246 | 0.580 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 170 | 0.580 |
Why?
|
| Stents | 1 | 2024 | 873 | 0.550 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 317 | 0.530 |
Why?
|
| Microbiota | 1 | 2022 | 436 | 0.510 |
Why?
|
| Hospitalization | 1 | 2021 | 1894 | 0.390 |
Why?
|
| Ureteral Neoplasms | 1 | 2009 | 27 | 0.300 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2009 | 64 | 0.300 |
Why?
|
| Humans | 24 | 2025 | 132327 | 0.300 |
Why?
|
| Treatment Outcome | 6 | 2025 | 13012 | 0.300 |
Why?
|
| Middle Aged | 11 | 2025 | 28870 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2020 | 2168 | 0.230 |
Why?
|
| Physicians, Women | 1 | 2025 | 52 | 0.220 |
Why?
|
| Incidental Findings | 3 | 2020 | 127 | 0.220 |
Why?
|
| Licensure | 1 | 2024 | 15 | 0.220 |
Why?
|
| Societies | 1 | 2024 | 27 | 0.220 |
Why?
|
| Operative Time | 1 | 2025 | 192 | 0.220 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 539 | 0.210 |
Why?
|
| Bayes Theorem | 1 | 2024 | 309 | 0.200 |
Why?
|
| Female | 11 | 2025 | 70818 | 0.200 |
Why?
|
| Education, Medical, Graduate | 2 | 2025 | 564 | 0.200 |
Why?
|
| Aged | 6 | 2025 | 21361 | 0.190 |
Why?
|
| Urogenital System | 1 | 2022 | 36 | 0.180 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17352 | 0.180 |
Why?
|
| United States | 4 | 2025 | 11617 | 0.180 |
Why?
|
| Sex Factors | 1 | 2025 | 1352 | 0.180 |
Why?
|
| Postoperative Complications | 2 | 2025 | 3139 | 0.180 |
Why?
|
| Para-Aortic Bodies | 1 | 2020 | 2 | 0.170 |
Why?
|
| Standard of Care | 1 | 2021 | 135 | 0.170 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2020 | 11 | 0.170 |
Why?
|
| Perioperative Period | 1 | 2020 | 52 | 0.170 |
Why?
|
| Personnel Selection | 1 | 2021 | 69 | 0.160 |
Why?
|
| Robotics | 2 | 2012 | 108 | 0.160 |
Why?
|
| Hemangioma | 1 | 2020 | 97 | 0.160 |
Why?
|
| Urologic Diseases | 1 | 2019 | 45 | 0.160 |
Why?
|
| Preoperative Care | 1 | 2021 | 370 | 0.150 |
Why?
|
| Length of Stay | 1 | 2025 | 1378 | 0.150 |
Why?
|
| Male | 9 | 2025 | 65037 | 0.150 |
Why?
|
| Risk Factors | 2 | 2025 | 10903 | 0.150 |
Why?
|
| Lymph Node Excision | 1 | 2019 | 171 | 0.150 |
Why?
|
| Guideline Adherence | 1 | 2021 | 395 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1247 | 0.150 |
Why?
|
| Patient Transfer | 1 | 2019 | 110 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 192 | 0.150 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 443 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 1723 | 0.140 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 332 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 189 | 0.140 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2017 | 11 | 0.130 |
Why?
|
| Research Design | 1 | 2021 | 749 | 0.130 |
Why?
|
| Tomography, Emission-Computed | 1 | 2017 | 38 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 3019 | 0.130 |
Why?
|
| Biopsy | 1 | 2020 | 1287 | 0.130 |
Why?
|
| Diuretics | 1 | 2017 | 156 | 0.120 |
Why?
|
| Ureteral Obstruction | 1 | 2017 | 105 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1304 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3852 | 0.110 |
Why?
|
| Quality of Life | 1 | 2024 | 2150 | 0.100 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 39 | 0.100 |
Why?
|
| Living Donors | 1 | 2013 | 116 | 0.090 |
Why?
|
| Warm Ischemia | 1 | 2012 | 26 | 0.090 |
Why?
|
| Adult | 4 | 2025 | 31602 | 0.090 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2011 | 23 | 0.090 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 24 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 440 | 0.090 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 159 | 0.090 |
Why?
|
| Teaching | 2 | 2024 | 200 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5403 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 803 | 0.080 |
Why?
|
| Cystoscopy | 1 | 2009 | 46 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1442 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2012 | 488 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2303 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2023 | 1071 | 0.050 |
Why?
|
| Foreign Medical Graduates | 1 | 2024 | 12 | 0.050 |
Why?
|
| Computer-Assisted Instruction | 1 | 2024 | 54 | 0.050 |
Why?
|
| Achievement | 1 | 2024 | 32 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 3087 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 3975 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2023 | 122 | 0.050 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2020 | 11 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2020 | 144 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 7105 | 0.040 |
Why?
|
| Abdomen | 1 | 2020 | 135 | 0.040 |
Why?
|
| Radioactive Tracers | 1 | 2017 | 22 | 0.030 |
Why?
|
| Renal Elimination | 1 | 2017 | 10 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 2017 | 137 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2017 | 109 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 131 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 333 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1186 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2146 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2011 | 47 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 64 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 109 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1963 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 1332 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 9936 | 0.010 |
Why?
|